Viewing Study NCT01757405

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-04-24 @ 3:07 AM
Study NCT ID: NCT01757405
Status: COMPLETED
Last Update Posted: 2021-05-11
First Post: 2012-12-21
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen
Sponsor: Baxalta now part of Shire
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
None Hemophilia B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None with Factor VIII (FVIII) or Factor IX (FIX) inhibitors View